Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

professional complementary health formulas - l-taurine 15x, 20x, 30x, 60x, 200x - for the temporary relief of muscle fatigue, cramping, or spasm, difficulty losing weight, anxiousness, sadness, restlessness, or sleep disturbance.* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

professional complementary health formulas - l-taurine 4x, 7x, 12x - for the temporary relief of muscle fatigue, cramping, or spasm, difficulty losing weight, anxiousness, sadness, restlessness, or sleep disturbance.* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

Јапан - Енглески - すりの適正使用協議会 RAD-AR Council, Japan

taisho pharmaceutical co., ltd. - taurine - white powder

Јапан - Енглески - すりの適正使用協議会 RAD-AR Council, Japan

taisho pharmaceutical co., ltd. - taurine - white powder

Велика Британија - Енглески - HMA (Heads of Medicines Agencies)

vita (europe) limited - tau-fluvalinate 11.84 % - bee-hive strip - bees - fluvalinate

Велика Британија - Енглески - myHealthbox

bayer ag -

Аустралија - Енглески - APVMA (Australian Pesticides and Veterinary Medicines Authority)

smart garden pty ltd - imidacloprid; tau-fluvalinate; myclobutanil - liquid - imidacloprid guanidine active 0.125 g/l; tau-fluvalinate pyrethroid active 0.1 g/l; myclobutanil triazole active 0.05 g/l - mixed function pesticide

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

novartis pharmaceuticals corporation - midostaurin (unii: id912s5von) (midostaurin - unii:id912s5von) - midostaurin 25 mg - rydapt is indicated in combination with standard cytarabine and daunorubicin induction and cytarabine consolidation chemotherapy, for the treatment of adult patients with newly diagnosed acute myeloid leukemia (aml) who are flt3 mutation-positive, as detected by an fda approved test [see dosage and administration (2.1), clinical studies (14.1)]. limitations of use rydapt is not indicated as a single-agent induction therapy for the treatment of patients with aml. rydapt is indicated for the treatment of adult patients with aggressive systemic mastocytosis (asm), systemic mastocytosis with associated hematological neoplasm (sm-ahn), or mast cell leukemia (mcl). rydapt is contraindicated in patients with hypersensitivity to midostaurin or to any of the excipients [see description (11)]. hypersensitivity reactions have included anaphylactic shock, dyspnea, flushing, chest pain, and angioedema (e.g., swelling of the airways or tongue, with or without respiratory impairment) [see adverse reactions (6.1)]. pregnanc

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

dna labs, inc. - bos taurus adrenal gland (unii: m2776swb29) (bos taurus adrenal gland - unii:m2776swb29), agrimonia eupatoria (unii: ebu0u94820) (agrimonia eupatoria - unii:ebu0u94820), bellis perennis (unii: 2hu33i03uy) (bellis perennis - unii:2hu33i03uy), camphor (natural) (unii: n20hl7q941) (camphor (natural) - unii:n20hl7q941), matricaria chamomilla (unii: g0r4ubi2zz) (matricaria chamomilla - unii:g0r4ubi2zz), equisetum hyemale (unii: 59677rxh25) (equisetum hyemale - unii:59677rxh25), fraxinus americana bark (uni - bos taurus adrenal gland 6 [hp_x] in 1 ml - constitutional treatment of inhalant allergies.

Европска Унија - Енглески - EMA (European Medicines Agency)

novartis europharm ltd - midostaurin - leukemia, myeloid, acute; mastocytosis - antineoplastic agents - rydapt is indicated:in combination with standard daunorubicin and cytarabine induction and high dose cytarabine consolidation chemotherapy, and for patients in complete response followed by rydapt single agent maintenance therapy, for adult patients with newly diagnosed acute myeloid leukaemia (aml) who are flt3 mutation positive (see section 4.2);as monotherapy for the treatment of adult patients with aggressive systemic mastocytosis (asm), systemic mastocytosis with associated haematological neoplasm (sm ahn), or mast cell leukaemia (mcl).